Alcohol use is a well characterized risk factor for traumatic brain injury (TBI); however, emerging clinical and experimental research suggests that TBI may also be an independent risk factor for the development of alcohol use disorders. In particular, TBIs incurred early in life predict the development of problem alcohol use and increase vulnerability to neuroinflammation as a consequence of alcohol use. Critically, the neuroinflammatory response to alcohol, mediated in large part by microglia, may also function as a driver of further alcohol use. Here, we tested the hypothesis that TBI increases alcohol consumption through microglia-mediated neuroinflammation. Mice were injured as juveniles and alcohol consumption and preference were assessed in a free-choice voluntary drinking paradigm in adolescence. TBI increased alcohol consumption; however, treatment with minocycline, an inhibitor of microglial activation, reduced alcohol intake in TBI mice to sham levels. Moreover, a single injection of ethanol (2 g/kg) significantly increased microglial activation in the nucleus accumbens and microglial expression of the proinflammatory cytokine IL-1b in TBI, but not sham or minocycline-treated, mice. Our data implicate TBI-induced microglial activation as a possible mechanism for the development of alcohol use disorders.
Introduction
The relationship between alcohol use and traumatic brain injury (TBI) is well documented. Clearly, there is substantial evidence that alcohol intoxication is an enormous risk factor for TBI (Bombardier et al., 2002; Opreanu et al., 2010) . However, there is also mounting evidence that the inverse relationship exists, specifically that TBI may itself be a risk factor for the development of problem alcohol use (Corrigan et al., 2013; Graham and Cardon, 2008; Ilie et al., 2015; Winqvist et al., 2007) . A history of TBI is a significant predictor of later alcohol abuse even among individuals that endured a mild TBI without loss of consciousness (Corrigan et al., 2013; Fishbein et al., 2016) . Critically, the age of TBI is strongly correlated to alcohol use, such that alcohol use problems are highest in individuals who experienced a TBI at a younger age (Corrigan et al., 2013; Fishbein et al., 2016; McKinlay et al., 2014) . Moreover, drinking after TBI is associated with poor rehabilitation outcomes, greater morbidity and a greatly increased chance of future head injuries (Corrigan, 1995; Vaaramo et al., 2014) . Given that young TBI patients are less likely to have developed problem drinking prior to injury, increasing evidence suggests that the vulnerability to alcohol abuse later in life is a consequence of TBIrelated pathology (Weil et al., 2016a; Weil and Karelina, 2017) .
We recently reported that mild TBI produces lasting alterations in dopaminergic signaling in key brain regions associated with reward processing (Karelina et al., 2017b) . Indeed there is strong evidence that the brain's reward circuitry undergoes pathophysiological alterations following brain injury resulting in not only altered dopamine signaling, but also functional abnormalities related to inflammation and cell death in the nucleus accumbens, ventral tegmental area (VTA), amygdala, and prefrontal cortex (Sajja et al., 2013; Shah et al., 2012; Shin et al., 2013) . Given the importance of these regions in establishing motivation for a rewarding substance (amygdala), dopamine release (VTA), and behavioral responses to rewarding stimuli (nucleus accumbens and prefrontal cortex), it is important to identify whether damage to these regions after TBI promotes alcohol (and other substance) abuse (Cardinal et al., 2002; Keitz et al., 2003; Kelley, 2004) .
While the mechanisms by which TBI increases the risk of alcohol abuse are not well understood, the development of animal models to study alcohol consumption after TBI has led to preliminary evidence for neuroinflammation as a potential proximate mediator. Neuroinflammation is a key component of TBI pathology. Inflammation occurs in the context of impaired cerebral perfusion,
